Multi-locus interactions predict risk for post-PTCA restenosis: An approach to the genetic analysis of common complex disease

被引:45
作者
Zee R.Y.L. [1 ]
Hoh J. [2 ]
Cheng S. [3 ]
Reynolds R. [3 ]
Grow M.A. [3 ]
Silbergleit A. [3 ]
Walker K. [3 ]
Steiner L. [3 ]
Zangenberg G. [3 ]
Fernandez-Ortiz A. [4 ]
Macaya C. [4 ]
Pintor E. [4 ]
Fernandez-Cruz A. [4 ]
Ott J. [2 ]
Lindpainter K. [1 ,5 ]
机构
[1] Department of Medicine, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA
[2] Laboratory of Statistical Genetics, Rockefeller University, New York, NY
[3] Department of Human Genetics, Roche Molecular Systems, Alameda, CA
[4] Hospital Universitario San Carlos, Ciudad Universitaria, Madrid
[5] F Hoffmann-La Roche Ltd., Ciudad Universitaria, Basel
关键词
Angioplasty; Restenosis; Risk factors; SNPs;
D O I
10.1038/sj.tpj.6500101
中图分类号
学科分类号
摘要
The complexity of recognizing the potential contribution of a number of possible predictors of complex disorders is increasingly challenging with the application of large-scale single nucleotide polymorphism (SNP) typing. In the search for putative genetic factors predisposing to coronary artery restenosis following balloon angioplasty, we determined genotypes for 94 SNPs representing 62 candidate genes, in a prospectively assembled cohort of 342 cases and 437 controls. Using a customized coupled-logistic regression procedure accounting for both additive and interactive effects, we identified seven SNPs in seven genes that, together, showed a statistically significant association with restenosis incidence (P <0.0001), accounting for 11.6% of overall variance observed. Among them are candidate genes for cardiovascular pathophysiology (apolipoprotein-species and NOS), inflammatory response (TNF receptor and CD14), and cell-cycle control (p53 and p53-associated protein). Our results emphasize the need to account for complex multi-gene influences and interactions when assessing the molecular pathology of multifactorial medical entities.
引用
收藏
页码:197 / 201
页数:4
相关论文
共 28 条
[11]  
Best P.J., Hasdai D., Sangiorgi G., Schwartz R.S., Holmes D.R., Simari R.D., Et al., Apoptosis. Basic concepts and implications in coronary artery disease, Arterioscler. Thromb. Vasc. Biol, 19, pp. 14-22, (1999)
[12]  
Mancini G.B., Simon S.B., McGillem M.J., LeFree M.T., Friedman H.Z., Vogel R.A., Automated quantitative coronary arteriography: Morphologic and physiologic validation in vivo of a rapid digital angiographic method, Circulation, 75, pp. 452-460, (1987)
[13]  
Alfonso F., Macaya C., Goicolea J., Iniguez A., Hernandez R., Zamorano J., Et al., Intravascular ultrasound imaging of angiographically normal coronary segments in patients with coronary artery disease, Am. Heart J, 127, pp. 536-544, (1994)
[14]  
Cheng S., Grow M.A., Pallaud C., Klitz W., Erlich H.A., Visvikis S., Et al., A multilocus genotyping assay for candidate markers of cardiovascular disease risk, Genome Res, 9, pp. 936-949, (1999)
[15]  
Stevens P.A., Brown M.J., Genetic variability of the ET-1 and the ETA receptor genes in essential hypertension, J. Cardiovasc. Pharmacol, 26, pp. S9-S12, (1995)
[16]  
Hubacek J.A., Rothe G., Pit'ha J., Skodova Z., Stanek V., Poledne R., Et al., C(-260)→T polymorphism in the promoter of the CD14 monocyte receptor gene as a risk factor for myocardial infarction, Circulation, 99, pp. 3218-3220, (1999)
[17]  
Mastuura S., Kishi F., Investigation of the polymorphic Avall site by a PCR-based assay at the human CD18 gene locus, Hum. Genet, 93, (1994)
[18]  
Behague I., Poirier O., Nicaud V., Evans A., Arveiler D., Luc G., Et al., Beta fibrinogen gene polymorphisms are associated with plasma fibrinogen and coronary artery disease in patients with myocardial infarction. The ECTIM Study. Etude Cas-Temoins sur I'Infarctus du Myocarde, Circulation, 93, pp. 440-449, (1996)
[19]  
Zhang B., Ye S., Herrmann S.M., Eriksson P., De Maat M., Evans A., Et al., Functional polymorphism in the regulatory region of gelatinase B gene in relation to severity of coronary atherosclerosis, Circulation, 99, pp. 1788-1794, (1999)
[20]  
Van den Velden P.A., Reitsma P.H., Amino acid dimorphism in IL1A is detectable by PCR amplification, Hum. Mol. Genet, 2, (1993)